2348 Share Price

Open 4.78 Change Price %
High 4.88 1 Day 0.03 0.63
Low 4.75 1 Week -0.28 -5.50
Close 4.81 1 Month 0.30 6.65
Volume 508000 1 Year -0.25 -4.94
52 Week High 5.75
52 Week Low 4.21
2348 Important Levels
Resistance 2 4.93
Resistance 1 4.88
Pivot 4.81
Support 1 4.74
Support 2 4.69
HKG HongKong Most Active Stocks
0566 3.91 0.00%
1880 6.24 0.00%
1398 5.36 -0.37%
8071 0.30 36.36%
0922 0.06 0.00%
3800 0.93 0.00%
0498 0.18 5.88%
0992 4.95 2.06%
0136 0.11 0.00%
3988 3.76 0.00%
More..
HKG HongKong Top Gainers Stocks
0875 0.03 50.00%
8071 0.30 36.36%
1002 0.31 19.23%
0943 0.07 16.67%
0833 2.94 16.67%
8337 0.15 15.38%
0568 1.65 15.38%
8129 0.08 14.29%
0681 0.09 12.50%
0582 0.09 12.50%
More..
HKG HongKong Top Losers Stocks
0904 0.02 -33.33%
0979 0.48 -18.64%
0076 0.05 -16.67%
0619 0.05 -16.67%
8002 4.00 -15.97%
0689 0.37 -15.91%
8028 0.06 -14.29%
1215 0.06 -14.29%
0616 0.06 -14.29%
1141 0.26 -13.33%
More..

Dawnrays Pharmaceutical (HKG: 2348)

2348 Technical Analysis 3
As on 21st Jul 2017 2348 Share Price closed @ 4.81 and we RECOMMEND Buy for LONG-TERM with Stoploss of 4.77 & Buy for SHORT-TERM with Stoploss of 4.73 we also expect STOCK to react on Following IMPORTANT LEVELS.
2348 Target for July
1st Target up-side 5.55
2nd Target up-side 5.89
3rd Target up-side 6.22
1st Target down-side 4.61
2nd Target down-side 4.27
3rd Target down-side 3.94
2348 Other Details
Segment EQ
Market Capital 0.00
Sector Healthcare
Industry Drug Manufacturers - Major
Offical website http://www.dawnrays.com
2348 Address
2348
CNT Tower
Units 3001-02
Wanchai,
Hong Kong
2348 Latest News
Dawnrays Pharmaceutical Holdings Ltd (2348.HK) Ichimoku Reveals Positive Momentum   Financial Newsweek   - 22nd Jul 17
Dawnrays Pharmaceutical Holdings Ltd (2348.HK) Reaches Active Mover List   Stock Rover   - 21st Jul 17
Chinese Infectious Disease Drugs Market Report 2015-2016 & 2021: Research into ...   GlobeNewswire (press release)   - 27th Mar 17
Dawnrays pharmaceutical says enters into JV agreement with Zhongshan KF   Reuters Key Development   - 14th Dec 16
Dawnrays Pharmaceutical says HY profit attributable RMB131.5 mln vs RMB 154.3 mln<2348.HK>   Reuters Key Development   - 26th Aug 16
Healthcare stocks in Hong Kong stand out as directors tone down buying and ...   South China Morning Post (subscription)   - 31st Jan 16
Chinese Pharmaceuticals Market: Trends, Reforms, Opportunities and Revenue ...   PR Newswire UK (press release)   - 26th Aug 15
Chinese Pharmaceutical Market: Forecasts and Outlooks 2014-2024   PR Newswire UK (press release)   - 29th Jul 14
India to Inspect Chinese Drug Manufacturers   2point6billion   - 09th Jan 12
11.28   MarketWatch   - 12th May 09
Interactive Technical Analysis Chart Dawnrays Pharmaceutical ( 2348 HKG HongKong )
Java support must be enabled in order to display FnCharts.
You can download Java from http://www.java.com
Your Comments and Response on Dawnrays Pharmaceutical
2348 Business Profile
Dawnrays Pharmaceutical (Holdings) Limited, an investment holding company, develops, manufactures, and sells non-patented pharmaceutical medicines in Mainland China, India, and other countries. The company operates in two segments, Intermediates and Bulk Medicines, and Finished Drug. It offers cephalosporin antibiotics cover intermediates, bulk medicines, and powder for injections; and specific medicines covering therapeutic areas for anti-HBV, anti-allergic, cardiovascular system, digestive system, urinary system, and endocrine system with dosage forms of tablets, capsules, and granules. The company was founded in 1995 and is headquartered in Wanchai, Hong Kong. Dawnrays Pharmaceutical (Holdings) Limited is a subsidiary of Fortune United Group Limited.